Stericycle Inc (SRCL) Holdings Trimmed by Fiduciary Trust Co.

Fiduciary Trust Co. cut its holdings in shares of Stericycle Inc (NASDAQ:SRCL) by 54.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 29,927 shares of the business services provider’s stock after selling 36,449 shares during the period. Fiduciary Trust Co.’s holdings in Stericycle were worth $1,629,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Louisiana State Employees Retirement System lifted its stake in Stericycle by 0.9% during the first quarter. Louisiana State Employees Retirement System now owns 22,800 shares of the business services provider’s stock worth $1,241,000 after purchasing an additional 200 shares during the last quarter. EagleClaw Capital Managment LLC lifted its stake in Stericycle by 2.3% during the first quarter. EagleClaw Capital Managment LLC now owns 13,150 shares of the business services provider’s stock worth $716,000 after purchasing an additional 300 shares during the last quarter. Cambridge Investment Research Advisors Inc. lifted its stake in shares of Stericycle by 5.8% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 6,650 shares of the business services provider’s stock valued at $244,000 after acquiring an additional 366 shares during the last quarter. Bbva Compass Bancshares Inc. lifted its stake in shares of Stericycle by 4.7% in the 1st quarter. Bbva Compass Bancshares Inc. now owns 9,716 shares of the business services provider’s stock valued at $529,000 after acquiring an additional 439 shares during the last quarter. Finally, Bronfman E.L. Rothschild L.P. lifted its stake in shares of Stericycle by 159.5% in the 4th quarter. Bronfman E.L. Rothschild L.P. now owns 807 shares of the business services provider’s stock valued at $30,000 after acquiring an additional 496 shares during the last quarter. Hedge funds and other institutional investors own 96.52% of the company’s stock.

A number of research analysts have recently commented on SRCL shares. Zacks Investment Research upgraded Stericycle from a “sell” rating to a “hold” rating in a research note on Wednesday, May 1st. ValuEngine upgraded Stericycle from a “strong sell” rating to a “sell” rating in a research note on Tuesday, March 5th. Robert W. Baird cut Stericycle from a “neutral” rating to an “underperform” rating and set a $44.00 price target for the company. in a research note on Wednesday, April 17th. BidaskClub upgraded Stericycle from a “sell” rating to a “hold” rating in a research note on Wednesday, February 13th. Finally, Goldman Sachs Group upgraded Stericycle from a “neutral” rating to a “buy” rating and set a $66.00 price target for the company in a research note on Friday, March 1st. Four investment analysts have rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the company’s stock. Stericycle presently has an average rating of “Hold” and a consensus price target of $59.00.

Shares of SRCL opened at $48.34 on Monday. Stericycle Inc has a 52 week low of $34.36 and a 52 week high of $71.43. The firm has a market capitalization of $4.40 billion, a PE ratio of 10.86, a PEG ratio of 1.88 and a beta of 1.11. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.02 and a quick ratio of 1.02.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Thursday, February 28th. The business services provider reported $1.03 EPS for the quarter, beating the Zacks’ consensus estimate of $0.96 by $0.07. Stericycle had a positive return on equity of 12.56% and a negative net margin of 8.92%. The company had revenue of $852.70 million during the quarter, compared to analysts’ expectations of $848.75 million. As a group, analysts expect that Stericycle Inc will post 3.34 EPS for the current year.

In related news, Director Mark C. Miller sold 260,314 shares of the firm’s stock in a transaction on Tuesday, April 9th. The stock was sold at an average price of $57.18, for a total transaction of $14,884,754.52. Following the completion of the transaction, the director now directly owns 325,848 shares of the company’s stock, valued at approximately $18,631,988.64. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.30% of the stock is owned by company insiders.

ILLEGAL ACTIVITY WARNING: This story was first published by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this story on another site, it was illegally copied and reposted in violation of U.S. & international copyright law. The correct version of this story can be read at https://www.baseballdailydigest.com/news/2019/05/20/stericycle-inc-srcl-holdings-trimmed-by-fiduciary-trust-co.html.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.

Read More: Reverse Stock Split

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.